CN111960983A - N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof - Google Patents

N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof Download PDF

Info

Publication number
CN111960983A
CN111960983A CN202010896249.0A CN202010896249A CN111960983A CN 111960983 A CN111960983 A CN 111960983A CN 202010896249 A CN202010896249 A CN 202010896249A CN 111960983 A CN111960983 A CN 111960983A
Authority
CN
China
Prior art keywords
tert
methylpyrrolidin
amine
reaction
pyrrole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010896249.0A
Other languages
Chinese (zh)
Inventor
朱金丽
陆麟霞
王敏敏
孙同明
王金
包文延
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong University
Original Assignee
Nantong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong University filed Critical Nantong University
Priority to CN202010896249.0A priority Critical patent/CN111960983A/en
Publication of CN111960983A publication Critical patent/CN111960983A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical

Abstract

The invention belongs to the technical field of organic synthesis, and relates to N-methyl-3- (1-methylpyrrolidine-3-yl) propane-1-amine and a synthesis method thereof. The compound provided by the invention can be used as an important medical intermediate, and the synthesis method comprises the following steps: the N-methyl-3- (1-methylpyrrolidine-3-yl) propan-1-amine is prepared by taking diethyl cyanomethylphosphonate and 3-formylpyrrolidine-1-carboxylic acid tert-butyl ester as raw materials and carrying out olefin, catalytic hydrogenation, reduction, substitution and reduction reactions, and the synthesis method has the advantages of simple synthesis path, low cost and high efficiency.

Description

N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof
Technical Field
The invention relates to the technical field of organic synthesis, and discloses N-methyl-3- (1-methylpyrrolidine-3-yl) propane-1-amine and a synthesis method thereof.
Background
The pyrrole derivatives are an important nitrogen heterocyclic compound, are used as an important alkaloid and widely exist in the whole natural world, wherein a large number of derivatives have good physiological and pharmacological activities. As such, pyrrole derivatives are widely used in the design of many drugs as important pharmaceutical intermediates. In addition, the pyrrole derivatives are important fine chemical product intermediates and have wide application in the fields of pesticides and the like. Therefore, the synthesis of pyrrole derivatives is of great significance.
Disclosure of Invention
The invention aims to provide a synthetic method of N-methyl-3- (1-methylpyrrolidin-3-yl) propane-1-amine serving as a compound of a medical intermediate, and the synthetic method is simple and high in yield.
In order to achieve the purpose, the technical scheme of the invention is as follows:
a compound is N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine, and the molecular structure is shown as formula 1:
Figure BDA0002658510660000011
the invention also provides a synthesis method of the compound, which takes the cyano-methyl diethyl phosphonate and the 3-formyl pyrrolidine-1-carboxylic acid tert-butyl ester as raw materials to synthesize the compound through five steps of alkene, catalytic hydrogenation, reduction, substitution and reduction reaction, and the synthesis route is shown as the following formula:
Figure BDA0002658510660000012
the synthesis method comprises the following steps:
s1, dissolving diethyl cyanomethylphosphonate and 3-formyl pyrrolidine-1-carboxylic acid tert-butyl ester in tetrahydrofuran to obtain a mixed solution, cooling to 0 ℃ after the mixed solution is clarified, adding potassium tert-butoxide in batches, slowly heating to room temperature, and stirring for reaction for 12 hours to obtain E-3- (1-acrylonitrile group) pyrrole-1-carboxylic acid tert-butyl ester;
s2, dissolving the E-3- (1-acrylonitrile group) pyrrole-1-tert-butyl formate obtained in the step S1 in methanol, adding a catalyst Pd/C under the protection of nitrogen, filling hydrogen, and stirring and reacting at room temperature for 12 hours to obtain E-3- (1-acrylonitrile group) pyrrole-1-tert-butyl formate;
s3, adding lithium aluminum hydride into a reaction bottle, slowly dropwise adding tetrahydrofuran, controlling the reaction temperature to be 60-70 ℃, slowly dropwise adding a tetrahydrofuran solution of the E-3- (1-propionitrile) pyrrole-1-tert-butyl formate obtained in the step S2, and reacting for 12 hours to obtain (3- (1-methylpyrrolidin-3-yl) propane-1-amine;
s4, adding the 3- (1-methylpyrrolidin-3-yl) propan-1-amine obtained in the step S3 into a reaction bottle, adding triethylamine and sodium bicarbonate, adding a dichloromethane solution containing Boc2O, and stirring at room temperature for reaction for 12 hours to obtain 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester;
s5, adding lithium aluminum hydride into a reaction bottle, dropwise adding DMF, heating to 60-70 ℃, slowly dropwise adding a tetrahydrofuran solution containing 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester, and reacting for 12h to obtain N-methyl-3- (1-methylpyrrolidin-3-yl) propyl-1-amine.
Preferably, in the step S1, the molar ratio of diethyl cyanomethylphosphonate to tert-butyl 3-formylpyrrolidine-1-carboxylate to potassium tert-butoxide is 1:1.1: 1.2;
preferably, in the step S3, the molar ratio of the E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester to the lithium aluminum hydride is 1: 4.
Preferably, in the step S4, the molar ratio of the 3- (1-methylpyrrolidin-3-yl) propan-1-amine to the Boc2O is 1: 2.
Compared with the prior art, the invention provides a new medical intermediate, and the synthesis method provided by the invention has the advantages of simple synthesis path, low cost and high efficiency.
Detailed description of the invention
The following detailed description will provide specific embodiments of the present invention. These embodiments are merely illustrative and not intended to limit the scope or the principles of the invention, which is defined by the claims and includes obvious modifications and variations based thereon.
Example 1
S1, and E-3- (1-acrylonitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
in a 500mL four-neck flask, 17.7g of diethyl cyanomethylphosphonate and 21.92g of tert-butyl 3-formylpyrrolidine-1-carboxylate are dissolved in 150mL of tetrahydrofuran to obtain a mixed solution, after the mixed solution is clarified, the temperature is reduced to 0 ℃, 13.4g of potassium tert-butoxide is added in 5 batches, the temperature is slowly raised to room temperature for reaction for 12 hours, after the reaction is completely analyzed by thin-layer chromatography, 200mL of saturated ammonium chloride solution is added, ethyl acetate is extracted for 3 times (3X 500mL), anhydrous sodium sulfate is dried, the filtrate is concentrated to dryness, and the mixture passes through a column to obtain 20.15g of tert-butyl E-3- (1-acrylonitrile) pyrrole-1-carboxylate, wherein the yield is 85%.
S2, and E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
and (2) dissolving 20g of the E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester obtained in the step S1 in 160mL of methanol in a 500mL hydrogenation bottle, adding 2g of catalyst Pd/C under the protection of nitrogen, introducing hydrogen, stirring at room temperature, reacting for 12h, completely analyzing and reacting through liquid phase mass spectrum and thin layer chromatography, filtering the reaction liquid, and concentrating the filtrate obtained by filtering to obtain 18.12g of E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, wherein the yield is 91%.
S3 synthesis of (3- (1-methylpyrrolidine) -1-propylamine:
adding 11.4g of lithium aluminum hydride into a 500mL reaction bottle, dropwise adding 200mL of DMF, heating to 60 ℃, slowly dropwise adding 20mL of tetrahydrofuran solution containing 18.12g E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min until a large amount of solid is generated, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 5.46g of (3- (1-methylpyrrolidine) -1-propylamine with the yield of 51%.
S4 Synthesis of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate:
a250 mL reaction flask was charged with 5.46g of (3- (1-methylpyrrolidine) -1-propylamine, 3.7g of triethylamine and 2.4mL of sodium bicarbonate, and charged with a solution containing 7.98g of Boc2O in dichloromethane (48 mL) and the reaction stirred at room temperature for 12 h. The reaction of the starting materials was completed by TLC analysis, and the reaction solution was separated into layers, and the aqueous layer was extracted with methylene chloride 3 times (3X 500mL), washed with citric acid 3 times (3X 500mL), washed with saturated brine 3 times (3X 500mL), dried over anhydrous sodium sulfate, filtered, and concentrated to dryness to give a crude product, which was passed through a column to give 4.5g of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate in a yield of 76.8%.
S5, Synthesis of N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine:
adding 2.9g of lithium aluminum hydride into a 250mL reaction bottle, dropwise adding 70mL of DMF, heating to 60 ℃, slowly dropwise adding 10mL of tetrahydrofuran solution containing 4.5g of 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min, generating a large amount of solid, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 2.16g N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine with the yield of 51%.
Example 2
S1, and E-3- (1-acrylonitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
in a 500mL four-neck flask, 17.7g of diethyl cyanomethylphosphonate and 21.92g of tert-butyl 3-formylpyrrolidine-1-carboxylate are dissolved in 150mL of tetrahydrofuran to obtain a mixed solution, after the mixed solution is clarified, the temperature is reduced to 0 ℃, 13.4g of potassium tert-butoxide is added in 5 batches, the temperature is slowly increased to room temperature for reaction for 12 hours, after the reaction is completely analyzed by thin-layer chromatography, 200mL of saturated ammonium chloride solution is added, ethyl acetate is extracted for 3 times (3X 500mL), anhydrous sodium sulfate is dried, the filtrate is concentrated to dryness, and the mixture passes through a column to obtain 20.41g of tert-butyl E-3- (1-acrylonitrile) pyrrole-1-carboxylate, wherein the yield is 86.1%.
S2, and E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
and (2) dissolving 20g of the E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester obtained in the step S1 in 160mL of methanol in a 500mL hydrogenation bottle, adding 2g of catalyst Pd/C under the protection of nitrogen, introducing hydrogen, stirring at room temperature, reacting for 12h, completely analyzing and reacting through liquid phase mass spectrum and thin layer chromatography, filtering the reaction liquid, and concentrating the filtrate obtained by filtering to obtain 18.12g of E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, wherein the yield is 91%.
S3 synthesis of (3- (1-methylpyrrolidine) -1-propylamine:
adding 11.4g of lithium aluminum hydride into a 500mL reaction bottle, dropwise adding 200mL of DMF, heating to 66 ℃, slowly dropwise adding 20mL of tetrahydrofuran solution containing 18.12g E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min, generating a large amount of solid, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 5.6g of (3- (1-methylpyrrolidine) -1-propylamine with the yield of 52.3%.
S4 Synthesis of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate:
a250 mL reaction flask was charged with 5.46g of (3- (1-methylpyrrolidine) -1-propylamine, 3.7g of triethylamine and 2.4mL of sodium bicarbonate, and charged with a solution containing 7.98g of Boc2O in dichloromethane (48 mL) and the reaction stirred at room temperature for 12 h. The reaction of the starting materials was completed by TLC analysis, and the reaction solution was separated into layers, and the aqueous layer was extracted with methylene chloride 3 times (3X 500mL), washed with citric acid 3 times (3X 500mL), washed with saturated brine 3 times (3X 500mL), dried over anhydrous sodium sulfate, filtered, and the filtrate was concentrated to dryness to give a crude product, which was passed through a column to give 4.5g of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate in a yield of 76.8%.
S5, Synthesis of N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine:
adding 2.9g of lithium aluminum hydride into a 250mL reaction bottle, dropwise adding 70mL of DMF, heating to 66 ℃, slowly dropwise adding 10mL of tetrahydrofuran solution containing 4.5g of 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min until a large amount of solid is generated, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 2.24g N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine with the yield of 53%.
Example 3
S1, and E-3- (1-acrylonitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
in a 500mL four-neck flask, 17.7g of diethyl cyanomethylphosphonate and 21.92g of tert-butyl 3-formylpyrrolidine-1-carboxylate are dissolved in 150mL of tetrahydrofuran to obtain a mixed solution, after the mixed solution is clarified, the temperature is reduced to 0 ℃, 13.4g of potassium tert-butoxide is added in 5 batches, the temperature is slowly increased to room temperature for reaction for 12 hours, after the reaction is completely analyzed by thin-layer chromatography, 200mL of saturated ammonium chloride solution is added, ethyl acetate is extracted for 3 times (3X 500mL), anhydrous sodium sulfate is dried, the filtrate is concentrated to dryness, and the mixture passes through a column to obtain 19.98g of tert-butyl E-3- (1-acrylonitrile) pyrrole-1-carboxylate, wherein the yield is 84.3%.
S2, and E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester synthesis:
and (2) dissolving 20g of the E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester obtained in the step S1 in 160mL of methanol in a 500mL hydrogenation bottle, adding 2g of catalyst Pd/C under the protection of nitrogen, introducing hydrogen, stirring at room temperature, reacting for 12h, completely analyzing and reacting through liquid phase mass spectrum and thin layer chromatography, filtering the reaction liquid, and concentrating the filtrate obtained by filtering to obtain 18.12g of E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, wherein the yield is 91%.
S3 synthesis of (3- (1-methylpyrrolidine) -1-propylamine:
adding 11.4g of lithium aluminum hydride into a 500mL reaction bottle, dropwise adding 200mL of DMF, heating to 70 ℃, slowly dropwise adding 20mL of tetrahydrofuran solution containing 18.12g E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min, generating a large amount of solid, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 5.56g of (3- (1-methylpyrrolidine) -1-propylamine with the yield of 51.9%.
S4 Synthesis of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate:
a250 mL reaction flask was charged with 5.46g of (3- (1-methylpyrrolidine) -1-propylamine, 3.7g of triethylamine and 2.4mL of sodium bicarbonate, and charged with a solution containing 7.98g of Boc2O in dichloromethane (48 mL) and the reaction stirred at room temperature for 12 h. The reaction of the starting materials was analyzed by thin layer chromatography, the reaction solution was separated into layers, the aqueous layer was extracted with methylene chloride 3 times (3X 500mL), washed with citric acid 3 times (3X 500mL), and washed with saturated brine3 times (3X 500mL), dried over anhydrous sodium sulfate, filtered, and the filtrate concentrated to dryness to give the crude product, which was passed through a column to give 4.5g of tert-butyl 3- (1-methylpyrrolidin-3-yl) propylcarbamate in 76.8% yield.
S5, Synthesis of N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine:
adding 2.9g of lithium aluminum hydride into a 250mL reaction bottle, dropwise adding 70mL of DMF, heating to 70 ℃, slowly dropwise adding 10mL of tetrahydrofuran solution containing 4.5g of 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester, reacting for 12h, analyzing the reaction completion of raw materials through thin layer chromatography, cooling the reaction liquid to room temperature, adding 6mL of 2M sodium hydroxide solution and 12mL of water, mechanically stirring for 30min, generating a large amount of solid, filtering, concentrating the filtrate obtained by filtering to dryness to obtain a crude product, and further distilling to obtain 2.22g N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine with the yield of 52.3%.
While there have been shown and described what are at present considered the fundamental principles and essential features of the invention and its advantages, it will be apparent to those skilled in the art that the invention is not limited to the details of the foregoing exemplary embodiments, but is capable of other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims (5)

1. A compound, wherein the compound is N-methyl-3- (1-methylpyrrolidin-3-yl) propan-1-amine, and the molecular structure is shown as formula I:
Figure FDA0002658510650000011
2. the method for synthesizing the compound according to claim 1, wherein the compound is synthesized by olefin, catalytic hydrogenation, reduction, substitution and reduction reactions using diethyl cyanomethylphosphonate and tert-butyl 3-formylpyrrolidine-1-carboxylate as raw materials, and the synthetic route is shown as the following formula:
Figure FDA0002658510650000012
the synthesis method comprises the following steps:
s1, dissolving diethyl cyanomethylphosphonate and 3-formyl pyrrolidine-1-carboxylic acid tert-butyl ester in tetrahydrofuran to obtain a mixed solution, cooling to 0 ℃ after the mixed solution is clarified, adding potassium tert-butoxide in batches, slowly heating to room temperature, and stirring for reaction for 12 hours to obtain E-3- (1-acrylonitrile group) pyrrole-1-carboxylic acid tert-butyl ester;
s2, dissolving the E-3- (1-acrylonitrile group) pyrrole-1-tert-butyl formate obtained in the step S1 in methanol, adding a catalyst Pd/C under the protection of nitrogen, filling hydrogen, and stirring and reacting at room temperature for 12 hours to obtain E-3- (1-acrylonitrile group) pyrrole-1-tert-butyl formate;
s3, adding lithium aluminum hydride into a reaction bottle, slowly dropwise adding tetrahydrofuran, controlling the reaction temperature to be 60-70 ℃, slowly dropwise adding a tetrahydrofuran solution of the E-3- (1-propionitrile) pyrrole-1-tert-butyl formate obtained in the step S2, and reacting for 12 hours to obtain (3- (1-methylpyrrolidin-3-yl) propane-1-amine;
s4, adding the 3- (1-methylpyrrolidin-3-yl) propan-1-amine obtained in the step S3 into a reaction bottle, adding triethylamine and sodium bicarbonate, adding a dichloromethane solution containing Boc2O, and stirring at room temperature for reaction for 12 hours to obtain 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester;
s5, adding lithium aluminum hydride into a reaction bottle, dropwise adding DMF, heating to 60-70 ℃, slowly dropwise adding a tetrahydrofuran solution containing 3- (1-methylpyrrolidin-3-yl) propyl carbamic acid tert-butyl ester, and reacting for 12h to obtain N-methyl-3- (1-methylpyrrolidin-3-yl) propyl-1-amine.
3. The method of claim 2, wherein in step S1, the molar ratio of diethyl cyanomethylphosphonate, tert-butyl 3-formylpyrrolidine-1-carboxylate and potassium tert-butoxide is 1:1.1: 1.2.
4. The method of claim 2, wherein in step S3, the molar ratio of E-3- (1-propionitrile) pyrrole-1-carboxylic acid tert-butyl ester to lithium aluminum hydride is 1: 4.
5. The method of claim 2, wherein in step S4, the molar ratio of 3- (1-methylpyrrolidin-3-yl) propan-1-amine to Boc2O is 1: 2.
CN202010896249.0A 2020-08-31 2020-08-31 N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof Pending CN111960983A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010896249.0A CN111960983A (en) 2020-08-31 2020-08-31 N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010896249.0A CN111960983A (en) 2020-08-31 2020-08-31 N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof

Publications (1)

Publication Number Publication Date
CN111960983A true CN111960983A (en) 2020-11-20

Family

ID=73399430

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010896249.0A Pending CN111960983A (en) 2020-08-31 2020-08-31 N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof

Country Status (1)

Country Link
CN (1) CN111960983A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036560A1 (en) * 2000-10-30 2002-05-10 Warner-Lambert Company Llc Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
WO2007138033A1 (en) * 2006-05-30 2007-12-06 Glaxo Group Limited 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
WO2009158011A1 (en) * 2008-06-26 2009-12-30 Amgen Inc. Alkynyl alcohols as kinase inhibitors
WO2012006475A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012054110A2 (en) * 2010-07-07 2012-04-26 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN102458581A (en) * 2009-05-22 2012-05-16 因塞特公司 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
US20140228358A1 (en) * 2011-09-22 2014-08-14 Jason Brubaker Acyclic cyanoethylpyrazoles as janus kinase inhibitors
CN106608896A (en) * 2015-10-26 2017-05-03 江苏福瑞生物医药有限公司 Synthesizing method for drug intermediate

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036560A1 (en) * 2000-10-30 2002-05-10 Warner-Lambert Company Llc Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis
WO2007138033A1 (en) * 2006-05-30 2007-12-06 Glaxo Group Limited 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands
WO2009158011A1 (en) * 2008-06-26 2009-12-30 Amgen Inc. Alkynyl alcohols as kinase inhibitors
CN102458581A (en) * 2009-05-22 2012-05-16 因塞特公司 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
WO2012006475A1 (en) * 2010-07-07 2012-01-12 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
WO2012054110A2 (en) * 2010-07-07 2012-04-26 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20140228358A1 (en) * 2011-09-22 2014-08-14 Jason Brubaker Acyclic cyanoethylpyrazoles as janus kinase inhibitors
CN106608896A (en) * 2015-10-26 2017-05-03 江苏福瑞生物医药有限公司 Synthesizing method for drug intermediate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANZE MEDEN等: "Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer’s disease", 《CHEM. COMMUN.》 *
CHEMICAL ABSTRACT SERVICE: "RN: 1554043-49-0", 《CA网络版STN REGISTRY数据库》 *
黄宪: "《新编有机合成化学》", 31 January 2003 *

Similar Documents

Publication Publication Date Title
US11702444B2 (en) Method for preparing natural bioactive peptide Tubulysin U
CA2856609C (en) Process for the preparation of sterol derivatives
CN112062756A (en) Mannhouse donor-acceptor adduct of furan and 3-pyridine ethylamine activated by Merlox acid and synthetic method thereof
CN114751872A (en) Column [5] arene N-heterocyclic carbene catalyst and preparation method and application thereof
CN112062712A (en) Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride
CN109096122B (en) Process for preparing spermidine
CN110669002B (en) Synthetic method of 2-fluoro-3-hydroxypyridine-4-carboxylic acid
CN111960983A (en) N-methyl-3- (1-methylpyrrolidine-3-yl) propyl-1-amine and synthetic method thereof
CN113444083A (en) Preparation method of small molecule tyrosine kinase inhibitor
EP1995250A1 (en) Ligand, method for producing the same, and catalyst using the ligand
CN103204758A (en) Tetracyclic decene dimer synthesis method
CN111892544A (en) 3- (aminomethyl) -4- (4-fluorophenyl) piperazine-1-carboxylic acid tert-butyl ester and synthesis method thereof
CN107629039B (en) The preparation method and intermediate of deuterated acrylamide
CN112778189A (en) (3R,4S) -N-substituent-3-carboxylic acid-4-ethyl pyrrolidine, intermediate and lapatinib
CN112321599B (en) Synthesis method of drug intermediate 7-oxo-2-azaspiro [3.5] nonane
CN113999239B (en) Method for synthesizing diaza-bridge compound
CN114380840B (en) Synthesis of eribulin
CN109574860A (en) A method of preparing Vilantro
CN113480453B (en) Synthesis method of NH2-PEG5-NHBoc
CN113185439B (en) V-shaped chiral carboxylic acid ligand, preparation method and application thereof
CN113683574B (en) Method for synthesizing 1-methyl-1H-1, 2, 4-triazole-3-methyl formate
CN110330509B (en) Synthesis process of eucalyptus thioether
CN114805231B (en) Synthesis method of p-NH2-Bn-NOTA
CN114031601B (en) Preparation method of landiolol hydrochloride
CN110981734B (en) Preparation method of 2,4, 6-tribromo-N-methyl-N- (2,4, 6-tribromophenyl) aniline

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201120